The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).
The US FDA has approved the HeartWare Ventricular Assist ... device (LVAD), which helps the heart’s left ventricle to pump oxygen-rich blood to the body. The mechanical pump is designed for ...
The delayed action raises questions for some safety advocates about how and when issues with approved ... blood from the pump to the aorta could twist and stop blood flow. The FDA recall notice ...
Opinions expressed by Forbes Contributors are their own. Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham ...
The latest development in health is that the US Food and Drug Administration (FDA) on August 26 approved the expanded use of ...
Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...
Roche (ROG.S), opens new tab said on Friday that the FDA had approved its companion diagnostic test to identify patients who may be eligible for Vyloy. The FDA had previously declined to approve ...
director of the FDA's Center for Biologics Evaluation and Research. The vaccine, which was first approved in 2003 to be administered only by healthcare providers, contains a weakened form of live ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
The US Food and Drug Administration has approved Cobenfy ... and constipation. The FDA says people with known liver impairment or moderate to severe kidney impairment should not use the drug.
who directs the FDA's Center for Biologics Evaluation and Research. It's been a long time coming, however: MedImmune's FluMist was first approved in 2003 for folks ages 5 to 49 to prevent flu ...